slotkoers
Korea S.E.
00:00:00 28-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
7.360
KRW
|
-0,94%
|
|
+1,52%
|
-4,54%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
72.723
|
75.125
|
247.300
|
128.314
|
96.840
|
87.711
|
Bedrijfswaarde
1 |
59.042
|
62.058
|
233.099
|
107.717
|
73.626
|
64.836
|
K/w-verhouding
|
12,7
x
|
10,4
x
|
32,3
x
|
18,9
x
|
7,78
x
|
6,53
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1,37
x
|
1,24
x
|
4,03
x
|
2,08
x
|
1,21
x
|
0,98
x
|
Bedrijfswaarde/omzet
|
1,11
x
|
1,02
x
|
3,79
x
|
1,74
x
|
0,92
x
|
0,73
x
|
Bedrijfswaarde/EBITDA
|
6,2
x
|
4,53
x
|
21,1
x
|
8,6
x
|
4,07
x
|
3,35
x
|
Bedrijfswaarde/FCF
|
-98,8
x
|
608
x
|
-109
x
|
13,2
x
|
495
x
|
-22,7
x
|
FCF Yield
|
-1,01%
|
0,16%
|
-0,91%
|
7,56%
|
0,2%
|
-4,41%
|
Price to Book
|
0,76
x
|
0,53
x
|
2,27
x
|
1,12
x
|
0,77
x
|
0,66
x
|
Aantal aandelen (in duizenden)
|
11.593
|
11.593
|
11.418
|
11.406
|
11.393
|
11.376
|
Referentieprijs
2 |
6.273
|
6.480
|
21.658
|
11.250
|
8.500
|
7.710
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
53.277
|
60.648
|
61.438
|
61.754
|
80.007
|
89.135
|
EBITDA
1 |
9.530
|
13.697
|
11.053
|
12.518
|
18.088
|
19.353
|
Bedrijfsresultaat (EBIT)
1 |
5.851
|
9.415
|
6.621
|
7.982
|
13.656
|
13.991
|
Operationele Marge
|
10,98%
|
15,52%
|
10,78%
|
12,93%
|
17,07%
|
15,7%
|
Resultaat voor belastingen (EBT)
1 |
5.779
|
8.345
|
8.162
|
8.341
|
14.645
|
14.953
|
Nettowinst (verlies)
1 |
5.714
|
7.257
|
7.544
|
6.679
|
12.157
|
13.641
|
Nettomarge
|
10,72%
|
11,97%
|
12,28%
|
10,82%
|
15,2%
|
15,3%
|
WPA
2 |
492,9
|
626,0
|
670,3
|
594,1
|
1.093
|
1.180
|
Free Cash Flow
1 |
-597,5
|
102,1
|
-2.130
|
8.141
|
148,7
|
-2.857
|
FCF-marge
|
-1,12%
|
0,17%
|
-3,47%
|
13,18%
|
0,19%
|
-3,2%
|
Kasstroomconversie (ebitda)
|
-
|
0,75%
|
-
|
65,03%
|
0,82%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
1,41%
|
-
|
121,89%
|
1,22%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
13.682
|
13.068
|
14.200
|
20.597
|
23.214
|
22.875
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-598
|
102
|
-2.130
|
8.141
|
149
|
-2.857
|
ROE (netto-inkomsten/eigen vermogen)
|
6,14%
|
7,39%
|
7,23%
|
6,05%
|
10,3%
|
10,6%
|
ROA (netto-inkomsten/totale activa)
|
3,5%
|
5,25%
|
3,41%
|
3,93%
|
6,28%
|
5,92%
|
Totale activa
1 |
163.211
|
138.280
|
221.179
|
169.884
|
193.572
|
230.327
|
Nettoactief per aandeel
2 |
8.211
|
12.227
|
9.551
|
10.069
|
11.082
|
11.670
|
Cashflow per aandeel
2 |
149,0
|
359,0
|
370,0
|
653,0
|
444,0
|
650,0
|
Capex
1 |
8.335
|
9.730
|
8.801
|
3.343
|
10.351
|
13.604
|
Capex/omzet
|
15,64%
|
16,04%
|
14,33%
|
5,41%
|
12,94%
|
15,26%
|
Datum van publicatie
|
1/03/19
|
29/02/20
|
1/03/21
|
1/03/22
|
1/03/23
|
29/02/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -4,54% | 60,76 mln. | | +20,76% | 43,77 mld. | | +28,00% | 22,83 mld. | | +20,25% | 15,56 mld. | | +18,82% | 14,34 mld. | | +55,83% | 12,96 mld. | | -0,05% | 6,79 mld. | | -12,70% | 6,41 mld. | | -8,87% | 5,73 mld. | | +14,65% | 5,69 mld. |
Generieke geneesmiddelen
|